Strategic Partners A/S Overview
Get informed when a big investor buys or sells
+ Follow-11.25
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for OZYMF is -11.25. That is below the Healthcare sector average of 27.75. Investors often review this figure alongside Strategic Partners A/S's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, OZYMF currently prints -11.25 for PEG ratio, while the sector average sits near 27.75. That is roughly 140.5% below the sector mean. Large gaps often invite a closer look at Strategic Partners A/S's growth, margins, and balance sheet.
A PEG ratio of -11.25 for Strategic Partners A/S is not 'good' or 'bad' on its own. Compare it with the peer average (27.75) and with OZYMF's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting OZYMF's PEG ratio (-11.25), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Strategic Partners A/S's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
